The recent news coverage about the withdrawal of the popular heartburn medication Zantac and other ranitidine products from the shelves of drugstores around the nation is based on the finding of NDMA in the drugs. NDMA is considered a probable carcinogen (a cancer-causing chemical) by multiple national and international health organizations, and this makes these recent findings in Zantac significant.
The FDA shares the following important advice related to Zantac usage:
Anyone using over-the-counter Zantac or other ranitidine products should discontinue usage, dispose of any excess medication properly, and quit purchasing the medication – including compounded forms of ranitidine.
Anyone taking prescription ranitidine should discuss alternate treatment options with their healthcare providers – several safer options are available.
Zantac and similar medications have been associated with several specific types of cancer that include (but are not limited to):
You took Zantac to help with your heartburn and/or related health concerns, and cancer is obviously a serious side effect that would have dissuaded you from using the medication in the first place if you’d only known.
If you or someone you love regularly took Zantac or another ranitidine product and later developed cancer, an experienced drug injury attorney may be able to help.
The Food and Drug Administration (FDA) issued a market withdrawal of Zantac and all ranitidine products in April 2020 based on the NDMA finding. This withdrawal required that all Zantac and related products be removed from the shelves and unavailable for purchase by consumers due to mounting safety concerns related to the presence of NDMA.
The World Health Organization (WHO), the International Agency of Research on Cancer (IARC), and the Environmental Protection Agency (EPA) all deem NDMA a probable carcinogen, which is why it matters that NDMA is in Zantac, a popular and lucrative heartburn medication that was – until very recently – on the market for years.
NDMA refers to N-Nitrosodimethylamine, which is found both in natural and in certain chemical processes. Stanford University research has determined that enzymes within the human body probably chemically react with Zantac to produce elevated NDMA levels in those who regularly take the medication – and others like it – to treat heartburn, gastroesophageal reflux disease (GERD), ulcers, and other similar health concerns.
Those who take Zantac regularly often exhibit high levels of NDMA in their urine, which has led researchers to predict that the NDMA found is likely a byproduct of the drug (produced as a result of what is considered the inherent molecular instability of ranitidine).
Zantac has been linked to extremely serious side effects. If your Zantac usage leads to a cancer diagnosis, working closely with a dedicated drug injury lawyer with considerable experience tackling the drug companies head-on can help ensure that you obtain financial compensation that covers your damages in their entirety. Discuss your case and its unique circumstances with a formidable drug injury lawyer today.
2 years ago I was involved in a trucking accident involving a 14-wheeler truck that nearly disabled me for life. Steve fought to make sure that I received the most possible compensation for my injuries. I was about to take the insurance company’s lowball offer, but decided to call Steve first – it was the best decision I’ve made yet
NOAH TAFFELPersonal Injury Victim